SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-055673
Filing Date
2022-11-03
Accepted
2022-11-03 20:00:16
Documents
2
Period of Report
2022-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8079
2 EX-24 DOCUMENT attachment1.htm EX-24 3918
  Complete submission text file 0001209191-22-055673.txt   13386
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Issuer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SURFACE ONCOLOGY, INC. 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address
Adams Chandra (Reporting) CIK: 0001950700 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38459 | Film No.: 221359833